MedAI Verdict
Radiology

AI Radiology

Canon Medical AI

by Canon Medical Systems  ·  JP

Last verified

Canon's AI imaging portfolio under the Altivity umbrella, led by AiCE deep-learning reconstruction cleared as part of CT and MR scanners.

At a glance

Pricing
No public price. Sold with scanners.
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
—
HQ
JP
On this page

Independent score  ·  By our public rubric

26/100Niche fit
How it’s computed →
  • Regulatory & Compliance
    18/28

    FDA cleared (15 K-numbers on record)

  • Clinical Integration
    0/26

    No EHR integrations listed

  • Evidence Strength
    0/26

    No peer-reviewed coverage

  • Vendor & Market
    8.4/18

    Mid-tier funding and adoption

  • Sentiment & Transparency
    2.5/14

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • FDA clearance18/18

    FDA cleared (15 K-numbers on record)

  • HIPAA / SOC2 / BAA0/10

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/14

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/4

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/18

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/8

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal8/12

    Mid-tier funding and adoption

  • Years in market0/6

    Founded year not recorded

Sentiment & Transparency

  • Clinician sentiment (Reddit)0/9

    No clinician sentiment data available

  • Pricing transparency3/5

    Pricing on request, no public amounts

Scored October 15, 2026 · Public scoring method v1.1.0

Bottom line

Canon's AI imaging portfolio under the Altivity umbrella, led by AiCE deep-learning reconstruction cleared as part of CT and MR scanners.

No public price. Sold with scanners.

Editorial review  ·  By MedAI Verdict

Bottom line

Canon Medical AI is a family of imaging AI built into Canon's scanners and software, grouped under the Altivity name, and the lead product is AiCE, its deep learning image reconstruction for CT, MR, PET and X-ray. Canon Medical and its Olea Medical subsidiary announced in August 2026 an expansion of U.S. access to eyonis LCS, an AI lung cancer screening product, per GlobeNewswire.

Who owns Canon's imaging AI?

Canon Medical Systems Corporation, a subsidiary of Canon Inc., sells it. Canon bought Toshiba Medical Systems in a deal completed on 19 December 2016, which brought Olea Medical, acquired by Toshiba Medical in October 2015. Canon has since retired the Vital Images brand, and Olea files as a separate applicant at FDA.

What is in the family?

Canon's global site says Altivity brings its AI innovations in medical imaging "under a unified umbrella". Named members are AiCE, PIQE, Deep Learning Spectral, SURE Subtraction, AIDR 3D and an Automation Platform. Canon describes its AI-assisted imaging as "smart solutions, powered by AI" across "the entire care pathway".

AiCE was first applied in 2018 on the Aquilion Precision CT, and Canon announced a rollout across all CT segments in November 2023. Canon's materials claim up to 82.4 percent dose reduction and applicability to more than 98 percent of CT, MR and PET procedures. PIQE is super-resolution MRI. Canon also describes AI workflow automation in CT, Auto Scan Assist in MR and Olea tools for breast, perfusion and neuro. A company profile on akta.pro lists Vitrea advanced visualisation under Canon Medical Informatics.

What is the FDA record?

FDA's 510(k) database shows 98 clearances to Canon Medical Systems Corporation since 2018, and 28 of them carry AiCE or AiCE-i in the device name. The count is by device name. Examples are K182901 from July 2019 for Aquilion Precision, K222819 from March 2023 for Aquilion Serve with AiCE-i, K243335 from January 2025 for Vantage Galan 3T V10.0 and K253625 from March 2026 for Vantage Fortian and Orian 1.5T V10.0 with AiCE. Olea Medical has 8 clearances of its own.

Each clearance covers a scanner model that includes the reconstruction, not standalone software, so buying AiCE means buying or upgrading the scanner.

What does the evidence say?

The 82.4 percent dose reduction and the 98 percent applicability figure are Canon's own claims, and the dose figure comes from a phantom model observer study, not from clinical results.

How is AiCE priced?

Canon lists no price. AiCE reaches buyers inside scanner purchases, through enterprise and OEM deals.

The verdict

AiCE has been cleared on Canon CT and MR scanners since 2019, and 28 of Canon's clearances name it. Canon's headline dose and coverage figures are its own.

Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

Pricing

What it costs

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
Enterprise and OEM——No public price. Sold with scanners.

Source: vendor pricing page. Last checked October 15, 2026.

Compliance + integration

What deploys cleanly

Carries FDA 510(k) per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.